FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

741057007: Copanlisib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3543022011 Copanlisib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3543023018 Copanlisib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Copanlisib (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Copanlisib (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Phosphoinositide 3 kinase inhibitor (disposition) true Inferred relationship Some
Copanlisib (substance) Is a Phosphoinositide 3 kinase inhibitor true Inferred relationship Some
Copanlisib (substance) Is a Enzyme inhibitor false Inferred relationship Some
Copanlisib (substance) Is a Quinazoline (substance) true Inferred relationship Some
Copanlisib (substance) Is a Pyrimidine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Copanlisib dihydrochloride Is a False Copanlisib (substance) Inferred relationship Some
Product containing copanlisib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Copanlisib (substance) Inferred relationship Some 1
Copanlisib-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Copanlisib (substance) Inferred relationship Some 1
Product containing only copanlisib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Copanlisib (substance) Inferred relationship Some 1
Copanlisib only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Copanlisib (substance) Inferred relationship Some 1
Copanlisib dihydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Copanlisib (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start